Early DEtection of wEaring off in Parkinson disease: The DEEP study

F. Stocchi, A. Antonini, P. Barone, M. Tinazzi, M. Zappia, M. Onofrj, S. Ruggieri, L. Morgante, U. Bonuccelli, L. Lopiano, P. Pramstaller, A. Albanese, M. Attar, V. Posocco, D. Colombo, G. Abbruzzese

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective: Assessing the frequency of Wearing-Off (WO) in Parkinson's disease (PD) patients, and its impact on Quality of Life (QoL). Methods: Consecutive ambulatory patients, who were on dopaminergic treatment for ≥1 year, were included in this multicentre, observational cross-sectional study. In a single visit, WO was diagnosed based on neurologist assessment as well as using the validated Italian version of a patient self-rated 19-question Wearing-Off Questionnaire (WOQ-19); WO was defined for scores≥2. QoL was evaluated by the 8-item Parkinson's Disease Questionnaire (PDQ-8). Results: 617 subjects were included, with a mean anti-Parkinson treatment duration of 6.6±4.6 years, 87.2% were on levodopa treatment. Neurologists identified presence of WO in 351 subjects (56.9%), whereas 415 subjects (67.3%) were identified by the self-administered WOQ-19. In patients with a

Original languageEnglish
Pages (from-to)204-211
Number of pages8
JournalParkinsonism and Related Disorders
Volume20
Issue number2
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Parkinson Disease
Quality of Life
Levodopa
Therapeutics
Cross-Sectional Studies
Neurologists
Surveys and Questionnaires

Keywords

  • Parkinson's disease
  • Quality of life
  • Wearing-off
  • Wearing-off questionnaire

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neurology

Cite this

Stocchi, F., Antonini, A., Barone, P., Tinazzi, M., Zappia, M., Onofrj, M., ... Abbruzzese, G. (2014). Early DEtection of wEaring off in Parkinson disease: The DEEP study. Parkinsonism and Related Disorders, 20(2), 204-211. https://doi.org/10.1016/j.parkreldis.2013.10.027

Early DEtection of wEaring off in Parkinson disease : The DEEP study. / Stocchi, F.; Antonini, A.; Barone, P.; Tinazzi, M.; Zappia, M.; Onofrj, M.; Ruggieri, S.; Morgante, L.; Bonuccelli, U.; Lopiano, L.; Pramstaller, P.; Albanese, A.; Attar, M.; Posocco, V.; Colombo, D.; Abbruzzese, G.

In: Parkinsonism and Related Disorders, Vol. 20, No. 2, 02.2014, p. 204-211.

Research output: Contribution to journalArticle

Stocchi, F, Antonini, A, Barone, P, Tinazzi, M, Zappia, M, Onofrj, M, Ruggieri, S, Morgante, L, Bonuccelli, U, Lopiano, L, Pramstaller, P, Albanese, A, Attar, M, Posocco, V, Colombo, D & Abbruzzese, G 2014, 'Early DEtection of wEaring off in Parkinson disease: The DEEP study', Parkinsonism and Related Disorders, vol. 20, no. 2, pp. 204-211. https://doi.org/10.1016/j.parkreldis.2013.10.027
Stocchi, F. ; Antonini, A. ; Barone, P. ; Tinazzi, M. ; Zappia, M. ; Onofrj, M. ; Ruggieri, S. ; Morgante, L. ; Bonuccelli, U. ; Lopiano, L. ; Pramstaller, P. ; Albanese, A. ; Attar, M. ; Posocco, V. ; Colombo, D. ; Abbruzzese, G. / Early DEtection of wEaring off in Parkinson disease : The DEEP study. In: Parkinsonism and Related Disorders. 2014 ; Vol. 20, No. 2. pp. 204-211.
@article{a5d4eb6892224657b6d2594af8660b2b,
title = "Early DEtection of wEaring off in Parkinson disease: The DEEP study",
abstract = "Objective: Assessing the frequency of Wearing-Off (WO) in Parkinson's disease (PD) patients, and its impact on Quality of Life (QoL). Methods: Consecutive ambulatory patients, who were on dopaminergic treatment for ≥1 year, were included in this multicentre, observational cross-sectional study. In a single visit, WO was diagnosed based on neurologist assessment as well as using the validated Italian version of a patient self-rated 19-question Wearing-Off Questionnaire (WOQ-19); WO was defined for scores≥2. QoL was evaluated by the 8-item Parkinson's Disease Questionnaire (PDQ-8). Results: 617 subjects were included, with a mean anti-Parkinson treatment duration of 6.6±4.6 years, 87.2{\%} were on levodopa treatment. Neurologists identified presence of WO in 351 subjects (56.9{\%}), whereas 415 subjects (67.3{\%}) were identified by the self-administered WOQ-19. In patients with a",
keywords = "Parkinson's disease, Quality of life, Wearing-off, Wearing-off questionnaire",
author = "F. Stocchi and A. Antonini and P. Barone and M. Tinazzi and M. Zappia and M. Onofrj and S. Ruggieri and L. Morgante and U. Bonuccelli and L. Lopiano and P. Pramstaller and A. Albanese and M. Attar and V. Posocco and D. Colombo and G. Abbruzzese",
year = "2014",
month = "2",
doi = "10.1016/j.parkreldis.2013.10.027",
language = "English",
volume = "20",
pages = "204--211",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Early DEtection of wEaring off in Parkinson disease

T2 - The DEEP study

AU - Stocchi, F.

AU - Antonini, A.

AU - Barone, P.

AU - Tinazzi, M.

AU - Zappia, M.

AU - Onofrj, M.

AU - Ruggieri, S.

AU - Morgante, L.

AU - Bonuccelli, U.

AU - Lopiano, L.

AU - Pramstaller, P.

AU - Albanese, A.

AU - Attar, M.

AU - Posocco, V.

AU - Colombo, D.

AU - Abbruzzese, G.

PY - 2014/2

Y1 - 2014/2

N2 - Objective: Assessing the frequency of Wearing-Off (WO) in Parkinson's disease (PD) patients, and its impact on Quality of Life (QoL). Methods: Consecutive ambulatory patients, who were on dopaminergic treatment for ≥1 year, were included in this multicentre, observational cross-sectional study. In a single visit, WO was diagnosed based on neurologist assessment as well as using the validated Italian version of a patient self-rated 19-question Wearing-Off Questionnaire (WOQ-19); WO was defined for scores≥2. QoL was evaluated by the 8-item Parkinson's Disease Questionnaire (PDQ-8). Results: 617 subjects were included, with a mean anti-Parkinson treatment duration of 6.6±4.6 years, 87.2% were on levodopa treatment. Neurologists identified presence of WO in 351 subjects (56.9%), whereas 415 subjects (67.3%) were identified by the self-administered WOQ-19. In patients with a

AB - Objective: Assessing the frequency of Wearing-Off (WO) in Parkinson's disease (PD) patients, and its impact on Quality of Life (QoL). Methods: Consecutive ambulatory patients, who were on dopaminergic treatment for ≥1 year, were included in this multicentre, observational cross-sectional study. In a single visit, WO was diagnosed based on neurologist assessment as well as using the validated Italian version of a patient self-rated 19-question Wearing-Off Questionnaire (WOQ-19); WO was defined for scores≥2. QoL was evaluated by the 8-item Parkinson's Disease Questionnaire (PDQ-8). Results: 617 subjects were included, with a mean anti-Parkinson treatment duration of 6.6±4.6 years, 87.2% were on levodopa treatment. Neurologists identified presence of WO in 351 subjects (56.9%), whereas 415 subjects (67.3%) were identified by the self-administered WOQ-19. In patients with a

KW - Parkinson's disease

KW - Quality of life

KW - Wearing-off

KW - Wearing-off questionnaire

UR - http://www.scopus.com/inward/record.url?scp=84893681784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893681784&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2013.10.027

DO - 10.1016/j.parkreldis.2013.10.027

M3 - Article

C2 - 24275586

AN - SCOPUS:84893681784

VL - 20

SP - 204

EP - 211

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 2

ER -